Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced its 2025 priorities and upcoming catalysts for ...

GLP-1 (glucagon-like peptide-1) discovered in the 1980s functions as a hormone derived from the proglucagon sequence and was found to have a transformative impact on the treatment of diabetes and ...

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...

Discover how a new collaboration between UChicago and a New York investment firms aims to bridge a gap in bringing scientific ...

VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

DNA profiling technologies are rapidly advancing, creating the potential to identify individuals involved in making, packing and transporting illegal capsules by analyzing the exterior of the illicit ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

Advances in Experimental Pharmacology and Drug Discovery have encountered a crucial but often overlooked challenge: gender inequality. Despite the pivotal ...

Here, the authors report thiazolyl ketone inhibitors of cPLA2α starting from compound GK470 (AVX235), and the discovery of a more potent and selective lead, GK420 (AVX420), with significant ...

When a show like “Deadliest Catch” can last for 20 seasons—and even outlast a collapse in the Alaskan crab population—there is a decided hunger for something like “Harpoon Hunters ...